ASP9801
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Metastatic Cancer
Conditions
Metastatic Cancer, Solid Tumors, Advanced Cancer
Trial Timeline
Sep 3, 2019 → Apr 19, 2024
NCT ID
NCT03954067About ASP9801
ASP9801 is a phase 1 stage product being developed by Astellas Pharma for Metastatic Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT03954067. Target conditions include Metastatic Cancer, Solid Tumors, Advanced Cancer.
What happened to similar drugs?
20 of 20 similar drugs in Metastatic Cancer were approved
Approved (20) Terminated (8) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03954067 | Phase 1 | Completed |
Competing Products
20 competing products in Metastatic Cancer